APP (Aducanumab Biosimilar) Human mAb is a biosimilar antibody for Aducanumab. Aducanumab is a human monoclonal antibody that targets aggregated forms of amyloid beta (Aβ) derived from amyloid precursor protein (APP).
Endotoxin
<0.1 EU/μg of antibody
Product Usage Information
This product is intended for research use only (RUO). Optimal dilutions/concentrations should be determined by the end user.
Formulation
Supplied in 1X PBS, BSA and Azide Free.
Storage
Store at -20°C. This product will freeze at -20°C so it is recommended to aliquot into single-use vials to avoid multiple freeze/thaw cycles. A slight precipitate may be present and can be dissolved by gently vortexing. This will not interfere with antibody performance.
Specificity / Sensitivity
APP (Aducanumab Biosimilar) Human Monoclonal Antibody was confirmed to bind to its intended target aggregated Aβ using bio-layer interferometry.
Species Reactivity:
Human
Source / Purification
APP (Aducanumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Aducanumab is an antibody directed against aggregated Aβ.
